In a significant step forward for veterans' healthcare, SoftWave Tissue Regeneration Technologies (SoftWave TRT) has been awarded a Federal Supply Schedule Contract by the Department of Veterans Affairs. Effective from July 15, 2023, to July 14, 2028, the contract—numbered 36F79723D01671—falls under Schedule 65 II A, dedicated to Medical Equipment and Supplies as part of Federal Supply Schedule...Read More
At the May meeting, the Current Procedural Terminology (CPT) Editorial Panel approved the reimbursement code X170T that was developed and submitted by SoftWave for Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT). Kennesaw, GA, May, 4– In March 2022, Chris Holt joined SoftWave TRT as a strategic advisor and co-CEO, bolstering the company's growth and clinical...Read More
